End Stage Recurrent Ovarian Cancer
Links shared publicly online about this topic
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
hindawi.com — “Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer” View full resource at hindawi.com
Most Recently Shared on August 29, 2011 at 6:40 pm By:
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer: Thi... http://t.co/C0fygZk
CRITICAL CONDITION: Karen's Stage 3 Ovarian Cancer Video
vodpod.com — “Karen Dove loses her insurance because her deteriorating health forces her to quit her job as an apartment manager. When she begins experiencing severe recurrent abdominal pains, the doctors she contacts refuse to treat uninsured patients. A year later, after she finally finds a gynecologic oncologist willing to treat her, she is diagnosed with Stage 3 ovarian cancer, which is almost always fatal. Karen undergoes surgery and chemotherapy, which drives her cancer into remission but sinks her fami” View full resource at vodpod.com
Most Recently Shared on June 4, 2010 at 11:32 pm By:
Paul Cacciatore Patient Advocate
Karen Dove loses her insurance because her deteriorating health forces her to quit her job as an apartment manager. Wh… http://bit.ly/bLp3hY
Ovarian Cancer: eMedicine Oncology
emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 12, 2010 at 6:04 pm By:
Medscape Oncology Oncology and Health Site
Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA
Ovarian cancer surgery doesn't have to end fertility - Los Angeles Times
articles.latimes.com — “Young women diagnosed with an early stage of ovarian cancer may be able to have surgery for the disease without losing their fertility.Traditionally, treatment of ovarian cancer involves removal of” View full resource at articles.latimes.com
Most Recently Shared on August 10, 2009 at 4:56 am By:
Ovarian cancer surgery doesn't have to end fertility: For younger patients whose disease is at an ea.. http://bit.ly/OizQv
Oncology Article | Ovarian Neoplasms
mdlinx.com — “Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease” View full resource at mdlinx.com
Most Recently Shared on April 12, 2011 at 10:31 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and r... http://bit.ly/hH6IxF #oncology
Journal of Ovarian Research | Abstract | On the Path to Translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research
ovarianresearch.com — “Ovarian cancer continues to be the most lethal of the gynaecologic malignancies due to the lack of early detection, screening strategies and ineffective therapeutics for late-stage metastatic disease, particularly in the recurrent setting. The gathering of researchers investigating fundamental pathobiology of ovarian cancer and the clinicians who treat patients with this insidious disease is paramount to meeting the challenges we face. Since 2002, the Canadian Conference on Ovarian Cancer Resear” View full resource at ovarianresearch.com
Most Recently Shared on June 23, 2011 at 8:37 pm By:
Paul Cacciatore Patient Advocate
On the Path to Translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research. (Full Text) http://dld.bz/aewy3#
CA-125 change over time shows promise as screening tool for early detection of ovarian cancer
physorg.com — “Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas MD Anderson Cancer Center.” View full resource at physorg.com
Most Recently Shared on May 20, 2010 at 11:10 pm By:
PhysOrg Health News Health News
CA-125 change over time shows promise as screening tool for early detection of ovarian cancer http://tw.physorg.com/193599161
NHS Evidence - Gastroenterology and liver diseases - Palliative surgery versus medical management for bowel obstruction in ovarian cancer
library.nhs.uk — “Background Ovarian cancer is the sixth most common cancer among women and is usually diagnosed at an advanced stage. Bowel obstruction is a common feature of advanced or recurrent ovarian cancer. Patients with bowel obstruction are generally in poor physical condition with a limited life expectancy. Therefore, maintaining their QoL with effective symptom control is the main purpose of the management of bowel obstruction. Objectives To compare the effectiveness and safety of palliative surgery (s” View full resource at library.nhs.uk
Most Recently Shared on July 13, 2010 at 11:53 am By:
Palliative surgery versus medical management for bowel obstruction in ovarian cancer: Background Ovarian cancer is... http://bit.ly/cTpcq3
PREVIEW-New cancer data may be tonic for sickly Roche | Reuters
reuters.com — “* Roche drugs in focus at Oct 8-12 European cancer congress * Ovarian cancer study could lift Avastin sales forecasts * Roche filing for ovarian use in EU by end 2010, U.S. 2011 * Results due also” View full resource at reuters.com
Most Recently Shared on October 6, 2010 at 1:59 am By:
Men For A Cause (TM) Health Organization
PREVIEW-New cancer data may be tonic for sickly Roche http://ping.fm/E86Gt
EntreMed second quarter 2010 net loss increases to $0.62 per share
news-medical.net — “EntreMed, Inc.,a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and six-month periods ending June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 16, 2010 at 4:58 pm By:
Ovarian Cancer News: EntreMed second quarter 2010 net loss increases to $0.62 per share: EntreMed, Inc.,a clini... http://buzzup.com/17103
EntreMed reports $2.1 million net loss for third quarter 2010
news-medical.net — “EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for the three- and nine-month periods ending September 30, 2010.” View full resource at news-medical.net
Most Recently Shared on November 12, 2010 at 2:00 pm By:
Ovarian Cancer News: EntreMed reports $2.1 million net loss for third quarter 2010: EntreMed, Inc., a clinica... http://buzzup.com/1eq8v
Aeterna Zentaris posts net loss of $5.9 million for first-quarter 2010
news-medical.net — “Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today reported financial and operating results as at and for the three months ended March 31, 2010.” View full resource at news-medical.net
Most Recently Shared on May 13, 2010 at 3:43 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Aeterna Zentaris posts net loss of $5.9 million for first-quarter 2010: Aeterna Zentaris Inc., a la... http://bit.ly/b4Z2kq
Aeterna Zentaris second-quarter revenues decrease to $5.6 million
news-medical.net — “Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today reported financial and operating results for the second quarter ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 12, 2010 at 4:51 pm By:
Ovarian Cancer News: Aeterna Zentaris second-quarter revenues decrease to $5.6 million: Aeterna Zentaris Inc., ... http://buzzup.com/16k07
Genomic Health Announces New Data Reinforcing Clinical Utility Of Oncotype DX(R) In Multiple Breast Cancer Populations
medicalnewstoday.com — “Genomic health, inc. (nasdaq: ghdx) announced results from five new studies on its oncotype dx® breast cancer test, a multi-gene expression test that physicians currently use to predict the li” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2009 at 11:17 am By:
Genomic Health Announces New Data Reinforcing Clinical Utility Of Oncotype DX(R) In Multiple Breast Cancer Populations http://mnt.to/3vxb
Newsroom - MD Anderson Cancer Center
mdanderson.org — “Newsroom - MD Anderson Cancer Center” View full resource at mdanderson.org
Most Recently Shared on February 29, 2008 at 11:37 pm By:
M. D. Anderson News Kevin Fowler to Entertain at Polo on the Prairie 2008 http://tinyurl.com/2m3wvd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Ovarian Cancer OW
Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
Paul Cacciatore
Founder of Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
-
Medscape Oncology
Medical news, full text journal articles, clinical reference, expert commentary & community features vital for todays oncologist
Advertisement
